## ISRG: Intuitive Surgical, Inc. - XLV: Healthcare

### Executive Summary

No thesis match: MRS_20 -0.7% below STRENGTH zone (4.0-10.0%); PEG 2.79 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-5.3% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($541.00)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. Here's Why Intuitive Surgical, Inc. (ISRG) Fell More Than Broader Market**
- Source: Yahoo Finance | 20251201T225000 | Somewhat-Bullish | Relevance: 99%
- Intuitive Surgical, Inc. (ISRG) recently experienced a 1.07% drop, underperforming the S&P 500 but outperforming the Dow and Nasdaq. The company is projected to report an EPS of $2.25 and revenue of $2.72 billion for its upcoming earnings, indicating growth from the prior year. Despite trading at a premium to its industry with a Zacks Rank of #1 (Strong Buy), investors are advised to monitor analyst estimate adjustments.

**2. Examining Intuitive Surgicalâ€™s Valuation After Recent Robotic Surgery Advancements and Market Rally**
- Source: Simply Wall Street | 20251202T062754 | Neutral | Relevance: 99%
- This article analyzes Intuitive Surgical's (ISRG) valuation following recent advancements in robotic surgery and a market rally. It applies Discounted Cash Flow (DCF) and Price-to-Earnings (PE) analyses, both indicating the stock is currently overvalued compared to its intrinsic value and peer averages. The article also introduces "Narratives" on Simply Wall St's community page, showcasing varying fair value estimates from different investors for ISRG.

**3. OMERS ADMINISTRATION Corp Has $7.95 Million Holdings in Intuitive Surgical, Inc. $ISRG**
- Source: MarketBeat | 20251202T020926 | Somewhat-Bullish | Relevance: 99%
-  OMERS ADMINISTRATION Corp decreased its stake in Intuitive Surgical, Inc. to 14,637 shares valued at $7.95 million after selling 5,368 shares in Q2. Despite this, Intuitive Surgical outperformed quarterly expectations with $2.40 EPS and $2.51 billion in revenue, reflecting a 22.9% year-over-year increase. However, recent insider selling, including EVP Henry L. Charlton's sale of 13,731 shares for $7.96 million, indicates a total of $48.0 million in insider sales over the last three months.

**4. Scotia Capital Inc. Acquires 739 Shares of Intuitive Surgical, Inc. $ISRG**
- Source: MarketBeat | 20251202T010954 | Somewhat-Bullish | Relevance: 99%
-  Scotia Capital Inc. increased its stake in Intuitive Surgical (NASDAQ:ISRG) by 14.1% in Q2, acquiring 739 additional shares to hold 5,990 shares valued at $3.254 million. Institutional investors now own 83.64% of the company's stock, despite significant insider selling in the past 90 days. Analysts maintain a "Moderate Buy" consensus rating with an average target price of $608.92, following the company's recent beat on quarterly EPS and revenue estimates.

**5. Chmn Guthart Files To Sell 22,806 Of Intuitive Surgical Inc [ISRG]**
- Source: TradingView | 20251202T020821 | Neutral | Relevance: 99%
- Gary S. Guthart, Chairman of the Board of Intuitive Surgical Inc [ISRG], filed a Form 144 on December 1, 2025, proposing to sell 22,806 restricted shares. The sale is planned for approximately December 1, 2025, through Morgan Stanley Smith Barney LLC, pursuant to a prearranged trading plan (10b5-1). This filing allows the sale of restricted shares within 90 days of submission to the SEC.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 5 ($4.83M) |
| Sells | 10 ($1.12M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 35.6% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 4 |

**Top Holders:**
- Vanguard Group Inc: 9.4% (+0.8%)
- Blackrock Inc.: 8.8% (+0.1%)
- State Street Corpora: 4.3% (-0.1%)
- Price (T.Rowe) Assoc: 3.6% (-4.4%)
- Geode Capital Manage: 2.3% (+1.0%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-5.3% 5d) with bearish MACD, trend may be turning.
2. Premium valuation (P/E 58x, PEG 2.8x) vulnerable to multiple compression.
3. Market regime shift could impact high-beta names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 2.79 signals overvaluation risk, limited margin of safety. Forward P/E 58.4x stretched relative to 13% growth. Quality metrics strong (margin 29%). Balance sheet: strong liquidity (4.7x), low leverage (D/E 0.14). Insider buying signal ($4.8M), management confidence. Institutional flow bearish (4 selling vs 5 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $199.3B |
| Beta | 1.69 |
| 52W Range | $425.00 - $616.00 |
| Short Interest | 2.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.79 |
| Forward P/E | 58.4 |
| Current P/E | 65.8 |
| YoY Growth | 12.7% |
| EPS Direction | RISING |

### Technicals

MRS_20 deteriorating from 4.6% to -0.7% (-5.3% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 4.7pp (needs >4.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram bearish (-2.49), momentum weakening.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -0.66% (CS: 52) | Neutral |
| RSI_14 | 60.5 | Neutral |
| MACD Histogram | -2.49 | Bearish |
| vs SMA20 | 1.011x | Above |
| vs SMA50 | 1.117x | Above |
| vs SMA200 | 1.115x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $567.72
- **Stop Loss:** $541.00 (4.7% risk)
- **Target:** $594.44 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 37
- **Position Value:** $21,005.64
- **Portfolio %:** 21.01%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate improvement trajectory. VIX compression from 20.5 to 16.6 over 5 days signals declining fear, while 47% breadth shows narrow but recovering participation. Fed meeting in 6 days creates near-term uncertainty, but AI sector momentum and improving technical setups support selective positioning.*

### Earnings

**Next:** 2026-01-22 (Est: $2.24)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.99 | $2.40 | +20.7% |
| 2025Q2 | $1.92 | $2.19 | +14.1% |
| 2025Q1 | $1.73 | $1.81 | +4.4% |
| 2024Q4 | $1.79 | $2.21 | +23.7% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*